Literature DB >> 12746268

In vivo imaging with oligonucleotides for diagnosis and drug development.

B Tavitian1.   

Abstract

Molecular imaging, the science that combines non-invasive in vivo imaging and molecular biology, has begun to use labelled oligonucleotides as radiotracers. Antisense oligonucleotides target gene expression at the RNA level, while aptamer oligonucleotides are designed to hit proteins of interest. Oligonucleotides for imaging cover a large range of applications, from the invention of new contrast agents for diagnosis to exquisite research tools for the development of new drugs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12746268      PMCID: PMC1867756          DOI: 10.1136/gut.52.suppl_4.iv40

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  101 in total

1.  Keeping the biotechnology of antisense in context.

Authors:  C A Stein
Journal:  Nat Biotechnol       Date:  1999-03       Impact factor: 54.908

2.  Nucleic Acid Selection and the Challenge of Combinatorial Chemistry.

Authors:  Scott E. Osborne; Andrew D. Ellington
Journal:  Chem Rev       Date:  1997-04-01       Impact factor: 60.622

3.  Postexposure prophylaxis against prion disease with a stimulator of innate immunity.

Authors:  Shneh Sethi; Grayson Lipford; Hermann Wagner; Hans Kretzschmar
Journal:  Lancet       Date:  2002-07-20       Impact factor: 79.321

4.  Disposition and metabolism of oligodeoxynucleoside methylphosphonate following a single i.v. injection in mice.

Authors:  T L Chen; P S Miller; P O Ts'o; O M Colvin; T L Chem
Journal:  Drug Metab Dispos       Date:  1990 Sep-Oct       Impact factor: 3.922

Review 5.  In vivo studies with antisense oligonucleotides.

Authors:  S Akhtar; S Agrawal
Journal:  Trends Pharmacol Sci       Date:  1997-01       Impact factor: 14.819

6.  Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer.

Authors:  D S Wilbur; S W Hadley; M D Hylarides; P G Abrams; P A Beaumier; A C Morgan; J M Reno; A R Fritzberg
Journal:  J Nucl Med       Date:  1989-02       Impact factor: 10.057

7.  Synthesis of ribonucleosides and diribonucleoside phosphates containing 2-chloroethylamine and nitrogen mustard residues.

Authors:  A M Belikova; V F Zarytova; N I Grineva
Journal:  Tetrahedron Lett       Date:  1967-09       Impact factor: 2.415

8.  Antisense oligodeoxynucleotides: synthesis, biophysical and biological evaluation of oligodeoxynucleotides containing modified pyrimidines.

Authors:  Y S Sanghvi; G D Hoke; S M Freier; M C Zounes; C Gonzalez; L Cummins; H Sasmor; P D Cook
Journal:  Nucleic Acids Res       Date:  1993-07-11       Impact factor: 16.971

9.  In vivo properties of an anti-GnRH Spiegelmer: an example of an oligonucleotide-based therapeutic substance class.

Authors:  Britta Wlotzka; Susanne Leva; Bernd Eschgfäller; Jens Burmeister; Frank Kleinjung; Christine Kaduk; Peter Muhn; Holger Hess-Stumpp; Sven Klussmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-17       Impact factor: 11.205

10.  Resistance to degradation by nucleases of (2'S)-2'-deoxy-2'-C-methyloligonucleotides, novel potential antisense probes.

Authors:  A M Iribarren; D O Cicero; P J Neuner
Journal:  Antisense Res Dev       Date:  1994
View more
  11 in total

Review 1.  Single-photon emission computed tomography in neurotherapeutics.

Authors:  Michael D Devous
Journal:  NeuroRx       Date:  2005-04

2.  In vivo biodistribution and pharmacokinetics of 18F-labelled Spiegelmers: a new class of oligonucleotidic radiopharmaceuticals.

Authors:  Raphaël Boisgard; Bertrand Kuhnast; Stefan Vonhoff; Chéraz Younes; Françoise Hinnen; Jean-Marc Verbavatz; Bernard Rousseau; Jens Peter Fürste; Britta Wlotzka; Frédéric Dollé; Sven Klussmann; Bertrand Tavitian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-12-22       Impact factor: 9.236

Review 3.  Imaging oncogene expression.

Authors:  Archana Mukherjee; Eric Wickstrom; Mathew L Thakur
Journal:  Eur J Radiol       Date:  2009-03-04       Impact factor: 3.528

4.  Radiolabeled oligonucleotides for antisense imaging.

Authors:  Arun K Iyer; Jiang He
Journal:  Curr Org Synth       Date:  2011-08-01       Impact factor: 1.975

5.  Application of locked nucleic acids to improve aptamer in vivo stability and targeting function.

Authors:  Kathrin S Schmidt; Sandra Borkowski; Jens Kurreck; Andrew W Stephens; Rolf Bald; Maren Hecht; Matthias Friebe; Ludger Dinkelborg; Volker A Erdmann
Journal:  Nucleic Acids Res       Date:  2004-10-27       Impact factor: 16.971

6.  Molecular imaging of atherosclerotic plaques with technetium-99m-labelled antisense oligonucleotides.

Authors:  Guangming Qin; Yongxue Zhang; Wei Cao; Rui An; Zairong Gao; Guiling Li; Wendai Xu; Kaijun Zhang; Shuren Li
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-11-26       Impact factor: 9.236

Review 7.  A Historical Review of Brain Drug Delivery.

Authors:  William M Pardridge
Journal:  Pharmaceutics       Date:  2022-06-16       Impact factor: 6.525

8.  Exploring the Structural Diversity of DNA Bottlebrush Polymers Using an Oligonucleotide Macromonomer Approach.

Authors:  Hao Lu; Jiansong Cai; Yang Fang; Mengqi Ren; Xuyu Tan; Fei Jia; Dali Wang; Ke Zhang
Journal:  Macromolecules       Date:  2022-03-01       Impact factor: 6.057

9.  Automated synthesis of an 18F-labelled pyridine-based alkylating agent for high yield oligonucleotide conjugation.

Authors:  Elisabeth von Guggenberg; Jayden A Sader; John S Wilson; Soraya Shahhosseini; Ingrid Koslowsky; Frank Wuest; John R Mercer
Journal:  Appl Radiat Isot       Date:  2009-04-19       Impact factor: 1.513

10.  Whole-body scanning PCR; a highly sensitive method to study the biodistribution of mRNAs, noncoding RNAs and therapeutic oligonucleotides.

Authors:  Julien A Boos; David W Kirk; Mari-Luz Piccolotto; Werner Zuercher; Sandro Gfeller; Philippe Neuner; Andre Dattler; William L Wishart; Fabian Von Arx; Michael Beverly; Jesper Christensen; Karine Litherland; Esther van de Kerkhof; Pieter J Swart; Thomas Faller; Armin Beyerbach; David Morrissey; Juerg Hunziker; Iwan Beuvink
Journal:  Nucleic Acids Res       Date:  2013-06-13       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.